Australia markets close in 3 hours 5 minutes

TScan Therapeutics, Inc. (TCRX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
7.29-0.09 (-1.22%)
At close: 04:00PM EDT
7.32 +0.03 (+0.41%)
After hours: 04:54PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
21,049
21,049
13,535
10,141
1,085
Operating expenses
Research development
88,153
88,153
59,819
44,954
20,577
Selling general and administrative
26,354
26,354
20,352
13,828
6,741
Total operating expenses
114,507
114,507
80,171
58,782
27,318
Operating income or loss
-93,458
-93,458
-66,636
-48,641
-26,233
Interest expense
3,759
3,759
1,176
0
-
Income before tax
-89,218
-89,218
-66,221
-48,625
-26,127
Income from continuing operations
-89,218
-89,218
-66,221
-48,625
-26,127
Net income
-89,218
-89,218
-66,221
-48,625
-26,127
Net income available to common shareholders
-89,218
-89,218
-66,221
-48,625
-26,127
Basic EPS
-2.02
-
-2.75
-4.17
-1.09
Diluted EPS
-2.02
-
-2.75
-4.17
-1.09
Basic average shares
47,803
-
24,048
11,663
23,938
Diluted average shares
47,803
-
24,048
11,663
23,938